$ACHC
Acadia Healthcare Company, Inc.

2023 Q2 Form 10-Q Financial Statement

#000095017023015296 Filed on April 27, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $731.3M $704.3M
YoY Change 12.22% 14.21%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $468.3M $469.7M
YoY Change 12.56% 15.24%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $32.01M $31.57M
YoY Change 9.9% 9.14%
% of Gross Profit
Operating Expenses $596.2M $592.2M
YoY Change 12.47% 14.32%
Operating Profit
YoY Change
Interest Expense -$20.91M -$20.00M
YoY Change 26.23% 26.68%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $96.43M $85.64M
YoY Change -12.06% 7.98%
Income Tax $22.88M $19.09M
% Of Pretax Income 23.73% 22.28%
Net Earnings $72.30M $66.02M
YoY Change -9.72% 8.51%
Net Earnings / Revenue 9.89% 9.37%
Basic Earnings Per Share $0.79 $0.73
Diluted Earnings Per Share $0.79 $0.72
COMMON SHARES
Basic Shares Outstanding 92.03M 91.31M
Diluted Shares Outstanding 91.55M 91.39M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $112.2M $63.83M
YoY Change -12.62% -54.53%
Cash & Equivalents $112.2M $63.83M
Short-Term Investments
Other Short-Term Assets $61.76M $127.6M
YoY Change -30.88% 40.62%
Inventory $5.437M $5.283M
Prepaid Expenses $26.88M $25.81M
Receivables $345.8M $346.4M
Other Receivables $53.55M $17.79M
Total Short-Term Assets $578.8M $537.8M
YoY Change 11.72% 1.45%
LONG-TERM ASSETS
Property, Plant & Equipment $2.202B $1.998B
YoY Change 18.54% 11.26%
Goodwill $2.223B $2.223B
YoY Change 0.79% 1.01%
Intangibles $71.61M $76.25M
YoY Change 1.98%
Long-Term Investments
YoY Change
Other Assets $75.38M $73.18M
YoY Change -17.42% -25.71%
Total Long-Term Assets $4.571B $4.506B
YoY Change 4.74% 4.69%
TOTAL ASSETS
Total Short-Term Assets $578.8M $537.8M
Total Long-Term Assets $4.571B $4.506B
Total Assets $5.150B $5.044B
YoY Change 5.48% 4.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $148.9M $125.7M
YoY Change 33.56% 20.65%
Accrued Expenses $208.2M $185.1M
YoY Change -7.66% -15.39%
Deferred Revenue $4.052M $5.097M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $24.90M $21.25M
YoY Change 17.16% 0.0%
Total Short-Term Liabilities $432.5M $378.1M
YoY Change -2.08% -7.94%
LONG-TERM LIABILITIES
Long-Term Debt $1.372B $1.400B
YoY Change -0.85% -4.38%
Other Long-Term Liabilities $240.9M $128.9M
YoY Change 106.01% -45.74%
Total Long-Term Liabilities $1.613B $1.529B
YoY Change 7.48% 4.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $432.5M $378.1M
Total Long-Term Liabilities $1.613B $1.529B
Total Liabilities $2.229B $2.114B
YoY Change 3.97% -6.46%
SHAREHOLDERS EQUITY
Retained Earnings $291.7M $219.4M
YoY Change 1278.23%
Common Stock $2.629B $2.620B
YoY Change -0.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.921B $2.840B
YoY Change
Total Liabilities & Shareholders Equity $5.150B $5.044B
YoY Change 5.48% 4.34%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $72.30M $66.02M
YoY Change -9.72% 8.51%
Depreciation, Depletion And Amortization $32.01M $31.57M
YoY Change 9.9% 9.14%
Cash From Operating Activities $163.8M $44.41M
YoY Change 9.76% -42.17%
INVESTING ACTIVITIES
Capital Expenditures $90.83M $66.53M
YoY Change -210.89% 31.66%
Acquisitions
YoY Change
Other Investing Activities $66.00K $794.0K
YoY Change -101.58% 72.61%
Cash From Investing Activities -$90.77M -$66.91M
YoY Change 5.43% 34.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -24.66M -11.32M
YoY Change -67.17% -44.9%
NET CHANGE
Cash From Operating Activities 163.8M 44.41M
Cash From Investing Activities -90.77M -66.91M
Cash From Financing Activities -24.66M -11.32M
Net Change In Cash 48.34M -33.82M
YoY Change -502.9% -616.02%
FREE CASH FLOW
Cash From Operating Activities $163.8M $44.41M
Capital Expenditures $90.83M $66.53M
Free Cash Flow $72.94M -$22.12M
YoY Change -68.44% -184.22%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001520697
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-35331
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Acadia Healthcare Company, Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-2492228
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
6100 Tower Circle
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1000
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Franklin
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
37067
CY2023Q1 dei City Area Code
CityAreaCode
615
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
861-6000
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $.01 par value
CY2023Q1 dei Trading Symbol
TradingSymbol
ACHC
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
92034672
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
63829000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
97649000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
346407000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
322439000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
86037000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
537790000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
506125000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1998037000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1952045000
CY2023Q1 us-gaap Goodwill
Goodwill
2222805000
CY2022Q4 us-gaap Goodwill
Goodwill
2222805000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
76247000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
76041000
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2918000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2950000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
133278000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
135238000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
73181000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
92697000
CY2023Q1 us-gaap Assets
Assets
5044256000
CY2022Q4 us-gaap Assets
Assets
4987901000
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
21250000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
21250000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
125729000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
104723000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
94912000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
125298000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
26415000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
26463000
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
109823000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
110592000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
378129000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
388326000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1399778000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1364541000
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
92767000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
92588000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
114592000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
116429000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
128933000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
125033000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Liabilities
Liabilities
2114199000
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
127554000
CY2022Q4 us-gaap Liabilities
Liabilities
2086917000
CY2023Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
90455000
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
88257000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
180000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
180000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
90953107
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
90953107
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
89913659
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
89913659
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
910000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
899000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2619289000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2658440000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
219403000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
153388000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2839602000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2812727000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5044256000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4987901000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
704267000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
616653000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7629000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7925000
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
391177000
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
335762000
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
41125000
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
36911000
CY2023Q1 us-gaap Supplies Expense
SuppliesExpense
26021000
CY2022Q1 us-gaap Supplies Expense
SuppliesExpense
23699000
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
11424000
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
11249000
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
90838000
CY2022Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
81425000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
31569000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
28926000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-19999000
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-15787000
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
6471000
CY2022Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
3582000
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
618624000
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
537341000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
85643000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
79312000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19085000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17402000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
66558000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
61910000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
66015000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
60837000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.68
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
543000
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1073000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
23968000
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.72
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.67
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90101000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89258000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
91391000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
91012000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2517489000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3749000
CY2022Q1 achc Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
RepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-15490000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7925000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
60837000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
2574510000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3148000
CY2022Q2 achc Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
RepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-1275000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6580000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
80079000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
2663042000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3067000
CY2022Q3 achc Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
RepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-740000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7240000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
71099000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
2743708000
CY2022Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1649000
CY2022Q4 achc Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
RepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-287000
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7890000
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-1357000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
61124000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2812727000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1203000
CY2023Q1 achc Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
RepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-48874000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7629000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
902000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
66015000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2839602000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
66558000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
61910000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
31569000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
28926000
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
824000
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
808000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7629000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7925000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
212000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3269000
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1089000
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
478000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18222000
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
23430000
CY2022Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
16638000
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1436000
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
202000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
13633000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
10501000
CY2023Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-30386000
CY2022Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
246000
CY2023Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
2114000
CY2022Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
6298000
CY2022Q1 achc Increase Decrease In Government Relief Funds
IncreaseDecreaseInGovernmentReliefFunds
-7556000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
44408000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
76787000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
66525000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
50527000
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
409000
CY2022Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1294000
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
794000
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
460000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-66910000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-49693000
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
40000000
CY2022Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
10000000
CY2023Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
5313000
CY2022Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
2656000
CY2023Q1 achc Proceeds From Payments For Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
ProceedsFromPaymentsForRepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-47671000
CY2022Q1 achc Proceeds From Payments For Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises
ProceedsFromPaymentsForRepurchaseOfSharesForPayrollTaxWithholdingNetOfProceedsFromStockOptionExercises
-11741000
CY2023Q1 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
1655000
CY2022Q1 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
4290000
CY2022Q1 us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
447000
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
11000
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
14000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11318000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-20540000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-33820000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6554000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
97649000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
133813000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
63829000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
140367000
CY2023Q1 achc Number Of Facilities
NumberOfFacilities
250
CY2023Q1 achc Number Of Beds
NumberOfBeds
11100
CY2023Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
39
CY2023Q1 us-gaap Change In Accounting Principle Accounting Standards Update Immaterial Effect
ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
true
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
66015000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
60837000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90101000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89258000
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1290000
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1754000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
91391000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
91012000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.68
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.72
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.67
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
500000
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
700000
CY2023Q1 achc Management Transition Costs
ManagementTransitionCosts
4800000
CY2022Q1 achc Management Transition Costs
ManagementTransitionCosts
1035000
CY2023Q1 achc Legal Accounting And Other Acquisition Related Costs
LegalAccountingAndOtherAcquisitionRelatedCosts
1640000
CY2022Q1 achc Legal Accounting And Other Acquisition Related Costs
LegalAccountingAndOtherAcquisitionRelatedCosts
589000
CY2023Q1 us-gaap Business Exit Costs1
BusinessExitCosts1
31000
CY2022Q1 us-gaap Business Exit Costs1
BusinessExitCosts1
1958000
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
6471000
CY2022Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
3582000
CY2023Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
45245000
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
5767000
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
25805000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
27052000
CY2023Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
17787000
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
15371000
CY2023Q1 achc Workers Compensation Deposits
WorkersCompensationDeposits
12000000
CY2022Q4 achc Workers Compensation Deposits
WorkersCompensationDeposits
12000000
CY2023Q1 us-gaap Insurance Receivable For Malpractice Current
InsuranceReceivableForMalpracticeCurrent
10989000
CY2022Q4 us-gaap Insurance Receivable For Malpractice Current
InsuranceReceivableForMalpracticeCurrent
10158000
CY2023Q1 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
8347000
CY2022Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
8347000
CY2023Q1 us-gaap Inventory Net
InventoryNet
5283000
CY2022Q4 us-gaap Inventory Net
InventoryNet
5087000
CY2023Q1 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
2098000
CY2022Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
2255000
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
127554000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
86037000
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2685526000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2608619000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
687489000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
656574000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1998037000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1952045000
CY2023Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
76247000
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
76041000
CY2023Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
77378000
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
77172000
CY2023Q1 achc Intangible Assets Accumulated Amortization Carrying Amount
IntangibleAssetsAccumulatedAmortizationCarryingAmount
1131000
CY2022Q4 achc Intangible Assets Accumulated Amortization Carrying Amount
IntangibleAssetsAccumulatedAmortizationCarryingAmount
1131000
CY2020 achc Income From Provider Relief Fund
IncomeFromProviderReliefFund
32800000
CY2021Q3 achc Expected Repay Of Payroll Tax Deferrals
ExpectedRepayOfPayrollTaxDeferrals
39300000
CY2023Q1 achc Accrued Expense Current
AccruedExpenseCurrent
20976000
CY2022Q4 achc Accrued Expense Current
AccruedExpenseCurrent
26699000
CY2023Q1 achc Cost Report Payable Current
CostReportPayableCurrent
18818000
CY2022Q4 achc Cost Report Payable Current
CostReportPayableCurrent
13738000
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
17411000
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
17596000
CY2023Q1 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
12128000
CY2022Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
12128000
CY2023Q1 achc Government Relief Funds Liability Current
GovernmentReliefFundsLiabilityCurrent
8975000
CY2022Q4 achc Government Relief Funds Liability Current
GovernmentReliefFundsLiabilityCurrent
8975000
CY2023Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
8404000
CY2022Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
9009000
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5097000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6653000
CY2023Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
990000
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
990000
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
45000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1338000
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
16979000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
13466000
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
109823000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
110592000
CY2023Q1 achc Debt Instrument Unamortized Issuance Costs Discount Premium Net
DebtInstrumentUnamortizedIssuanceCostsDiscountPremiumNet
12097000
CY2022Q4 achc Debt Instrument Unamortized Issuance Costs Discount Premium Net
DebtInstrumentUnamortizedIssuanceCostsDiscountPremiumNet
12647000
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
1421028000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
1385791000
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
21250000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
21250000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1399778000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1364541000
CY2023Q1 achc Number Of Facilities Operated By Non Wholly Owned Subsidiaries
NumberOfFacilitiesOperatedByNonWhollyOwnedSubsidiaries
8
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
88257000
CY2023Q1 us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
1655000
CY2023Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
543000
CY2023Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
90455000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
12700000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2885024
CY2023Q1 achc Share Based Compensation Arrangement By Share Based Payment Stock Options Granted Term
ShareBasedCompensationArrangementByShareBasedPaymentStockOptionsGrantedTerm
P10Y
CY2023Q1 achc Share Based Compensation Arrangement By Share Based Payment Award
ShareBasedCompensationArrangementByShareBasedPaymentAward
0.25
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7600000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7900000
CY2023Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense
78100000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P1Y6M
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1106069
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
42.07
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
334260
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
55.73
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
285577
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
40.66
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
175475
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
46.98
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
979277
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
46.27
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
226940
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
80.40
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
32491
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
37.01
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
19945
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
50.32
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1153781
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
53.17
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y8M15D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
24007000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
507616
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
42.08
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y3M7D
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
15315000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
31.80
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
20.72
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.042
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.020
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.37
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.39
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.223
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.219

Files In Submission

Name View Source Status
achc-20230331_def.xml Edgar Link unprocessable
achc-20230331_cal.xml Edgar Link unprocessable
0000950170-23-015296-index-headers.html Edgar Link pending
0000950170-23-015296-index.html Edgar Link pending
0000950170-23-015296.txt Edgar Link pending
0000950170-23-015296-xbrl.zip Edgar Link pending
achc-20230331.htm Edgar Link pending
achc-20230331.xsd Edgar Link pending
achc-ex10_1.htm Edgar Link pending
achc-ex31_1.htm Edgar Link pending
achc-ex31_2.htm Edgar Link pending
achc-ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
achc-20230331_lab.xml Edgar Link unprocessable
achc-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
achc-20230331_htm.xml Edgar Link completed
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending